New drug trial aims to control rare fat disorder
NCT ID NCT07220785
Summary
This study is testing an investigational drug called mibavademab in people with generalized lipodystrophy, a rare disorder where the body cannot store fat properly. The main goals are to see if the drug can improve high blood sugar and high fat levels in the blood, reduce fat in the liver, and is safe for both adults and children. Participants will be randomly assigned to receive either the study drug or a placebo to compare the effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GENERALIZED LIPODYSTROPHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Michigan
RECRUITINGAnn Arbor, Michigan, 48109, United States
Conditions
Explore the condition pages connected to this study.